CA2466415C - Pgc-1.beta., a novel pgc-1 homologue and uses therefor - Google Patents

Pgc-1.beta., a novel pgc-1 homologue and uses therefor Download PDF

Info

Publication number
CA2466415C
CA2466415C CA2466415A CA2466415A CA2466415C CA 2466415 C CA2466415 C CA 2466415C CA 2466415 A CA2466415 A CA 2466415A CA 2466415 A CA2466415 A CA 2466415A CA 2466415 C CA2466415 C CA 2466415C
Authority
CA
Canada
Prior art keywords
pgc
nucleic acid
activity
polypeptide
acid molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2466415A
Other languages
English (en)
French (fr)
Other versions
CA2466415A1 (en
Inventor
Bruce M. Spiegelman
Jiandie Lin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dana Farber Cancer Institute Inc
Original Assignee
Dana Farber Cancer Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Institute Inc filed Critical Dana Farber Cancer Institute Inc
Publication of CA2466415A1 publication Critical patent/CA2466415A1/en
Application granted granted Critical
Publication of CA2466415C publication Critical patent/CA2466415C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA2466415A 2001-11-09 2002-11-08 Pgc-1.beta., a novel pgc-1 homologue and uses therefor Expired - Lifetime CA2466415C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33812601P 2001-11-09 2001-11-09
US60/338,126 2001-11-09
PCT/US2002/035869 WO2003042362A2 (en) 2001-11-09 2002-11-08 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR

Publications (2)

Publication Number Publication Date
CA2466415A1 CA2466415A1 (en) 2003-05-22
CA2466415C true CA2466415C (en) 2020-01-21

Family

ID=23323511

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2466415A Expired - Lifetime CA2466415C (en) 2001-11-09 2002-11-08 Pgc-1.beta., a novel pgc-1 homologue and uses therefor

Country Status (6)

Country Link
US (4) US7091006B2 (de)
EP (1) EP1525323B1 (de)
JP (1) JP2005514921A (de)
AU (1) AU2002352558A1 (de)
CA (1) CA2466415C (de)
WO (1) WO2003042362A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2004015415A1 (ja) * 2002-08-08 2005-12-02 独立行政法人科学技術振興機構 薬剤スクリーニング方法
EP1774028A4 (de) * 2004-07-07 2008-05-07 Dana Farber Cancer Inst Inc Verfahren und zusammensetzungen zur behandlung von obesität
EP1802321A4 (de) * 2004-09-03 2009-12-02 Dana Farber Cancer Inst Inc Zusammensetzungen und verfahren zur modulierung von pgc-1-alpha zur behandlung neurologischer krankheiten und erkrankungen
EP1812041A2 (de) * 2004-10-22 2007-08-01 Dana-Farber Cancer Institute, Inc. Zusammensetzungen und verfahren zur modulierung von pgc-1 zur behandlung von mit lipiden zusammenhängenden erkrankungen und störungen
WO2006098314A1 (ja) * 2005-03-15 2006-09-21 Astellas Pharma Inc. 新規糖取り込み活性化剤及びそのスクリーニング法
BRPI0500959A (pt) * 2005-03-23 2006-11-21 Unicamp uso farmacológico de inibidor da expressão da proteìna coativador 1 alfa do receptor ativado por proliferador do peroxisoma (pgc-1(alfa)) para o tratamento de diabetes mellitus, resistência à insulina e sìndrome metabólica, seu composto e sua composição farmacêuticos
BRPI0711174A2 (pt) * 2006-05-03 2011-08-23 Novartis Ag uso de compostos orgánicos
WO2009020632A1 (en) * 2007-08-06 2009-02-12 Burnham Institute For Medical Research Znf206: a novel regulator of embryonic stem cell self-renewal and pluripotency
US8476227B2 (en) 2010-01-22 2013-07-02 Ethicon Endo-Surgery, Inc. Methods of activating a melanocortin-4 receptor pathway in obese subjects
US9044606B2 (en) 2010-01-22 2015-06-02 Ethicon Endo-Surgery, Inc. Methods and devices for activating brown adipose tissue using electrical energy
CN103889411B (zh) 2011-07-15 2018-03-16 纽斯尔特科学公司 用于调节代谢途径的组合物和方法
US9198454B2 (en) 2012-03-08 2015-12-01 Nusirt Sciences, Inc. Compositions, methods, and kits for regulating energy metabolism
SG10201709195TA (en) 2012-11-13 2017-12-28 Nusirt Sciences Inc Compositions and methods for increasing energy metabolism
US9766241B2 (en) 2012-12-26 2017-09-19 Toshihiro Nakajima PGC-1beta-protein-function regulator, mitochondria-function regulator, anti-obesity agent, and screening method therefor
AU2014236687A1 (en) 2013-03-15 2015-09-10 Nusirt Sciences, Inc. Leucine and nicotinic acid reduces lipid levels
WO2015131152A1 (en) 2014-02-27 2015-09-03 Nusirt Sciences Inc. Compositions and methods for the reduction or prevention of hepatic steatosis
US10080884B2 (en) 2014-12-29 2018-09-25 Ethicon Llc Methods and devices for activating brown adipose tissue using electrical energy
US10092738B2 (en) 2014-12-29 2018-10-09 Ethicon Llc Methods and devices for inhibiting nerves when activating brown adipose tissue
US11083702B2 (en) * 2016-04-19 2021-08-10 University of Pittsburgh—of the Commonwealth System of Higher Education Anaplerotic agents for treatment of disorders of propionate and long chain fat metabolism
WO2018093839A1 (en) * 2016-11-15 2018-05-24 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Therapy for mitochondrial fatty acid beta-oxidation and transport disorders
KR102660375B1 (ko) * 2020-12-15 2024-04-26 (주)디마인 PGC-1α 유래 펩타이드 유도체 및 그를 포함하는 화장료 조성물
CN117568398B (zh) * 2023-09-19 2024-06-04 新乡医学院 一种PGC-1α基因敲除小鼠构建心律失常动物模型的方法及其应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4870009A (en) 1982-11-22 1989-09-26 The Salk Institute For Biological Studies Method of obtaining gene product through the generation of transgenic animals
US4736866A (en) 1984-06-22 1988-04-12 President And Fellows Of Harvard College Transgenic non-human mammals
EP0264166B1 (de) 1986-04-09 1996-08-21 Genzyme Corporation Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern
US4873316A (en) 1987-06-23 1989-10-10 Biogen, Inc. Isolation of exogenous recombinant proteins from the milk of transgenic mammals
US5080891A (en) 1987-08-03 1992-01-14 Ddi Pharmaceuticals, Inc. Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
FR2646438B1 (fr) 1989-03-20 2007-11-02 Pasteur Institut Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration
WO1991001140A1 (en) 1989-07-25 1991-02-07 Cell Genesys, Inc. Homologous recombination for universal donor cells and chimeric mammalian hosts
AU8229291A (en) 1990-07-10 1992-02-04 Smithkline Beecham Corporation Oxamides
AU2515992A (en) 1991-08-20 1993-03-16 Genpharm International, Inc. Gene targeting in animal cells using isogenic dna constructs
ATE256738T1 (de) 1992-10-30 2004-01-15 Gen Hospital Corp Ein neues zellzyklus kontrollprotein
GB9517780D0 (en) 1995-08-31 1995-11-01 Roslin Inst Edinburgh Biological manipulation
GB9517779D0 (en) 1995-08-31 1995-11-01 Roslin Inst Edinburgh Biological manipulation
JP4495787B2 (ja) 1997-05-30 2010-07-07 ダナ−ファーバー キャンサー インスティテュート インク． ＰＧＣ−１、新規な褐色脂肪ＰＰＡＲ▲下γ▼コアクチベーター
US6426411B1 (en) * 1997-05-30 2002-07-30 Dana-Farber Cancer Institute PGC-1, a novel brown fat pparγ coactivator
WO2001054472A2 (en) * 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
EP1328636A2 (de) * 2000-09-01 2003-07-23 Nuvelo Inc. Nukleinsäuren und polypeptide
GB0022670D0 (en) * 2000-09-15 2000-11-01 Astrazeneca Ab Molecules
AU2002215956A1 (en) * 2000-10-17 2002-04-29 Bayer Aktiengesellschaft Regulation of human pgc-1-like protein
EP1812041A2 (de) * 2004-10-22 2007-08-01 Dana-Farber Cancer Institute, Inc. Zusammensetzungen und verfahren zur modulierung von pgc-1 zur behandlung von mit lipiden zusammenhängenden erkrankungen und störungen

Also Published As

Publication number Publication date
CA2466415A1 (en) 2003-05-22
AU2002352558A1 (en) 2003-05-26
US7354738B2 (en) 2008-04-08
US8445233B2 (en) 2013-05-21
WO2003042362A3 (en) 2005-03-03
WO2003042362A8 (en) 2004-05-21
US20120094293A1 (en) 2012-04-19
US8105774B2 (en) 2012-01-31
EP1525323B1 (de) 2015-01-21
US7091006B2 (en) 2006-08-15
JP2005514921A (ja) 2005-05-26
US20070009933A1 (en) 2007-01-11
US20080261224A1 (en) 2008-10-23
WO2003042362A2 (en) 2003-05-22
US20030124598A1 (en) 2003-07-03
EP1525323A4 (de) 2009-08-05
EP1525323A2 (de) 2005-04-27

Similar Documents

Publication Publication Date Title
US8105774B2 (en) PGC-1β, PGC-1 homologue and uses therefor
US20090098569A1 (en) Novel PGC-1 Isoforms and Uses Therefor
WO2002088378A2 (en) 66784, a novel human potassium channel and uses therefor
US20020081658A1 (en) 18610, a novel human transient receptor and uses thereof
US20020123098A1 (en) 55063, a novel human NMDA family member and uses thereof
WO2001077331A9 (en) Human trp-like calcium channel protein-2 (tlcc-2)
US20020081651A1 (en) 26649, a novel human GTPase activating molecule and uses therefor
US20020123097A1 (en) 63760, a novel human transporter and uses thereof
US20020123094A1 (en) 57250, a novel human sugar transporter family member and uses thereof
US20020081696A1 (en) 32529, a novel human guanine nucleotide exchange factor family member and uses thereof
WO2001074854A2 (en) 32449, a putative human transporter and uses thereof
US20020086357A1 (en) 32591, a novel human GTPase activating molecule and uses therefor
WO2002026983A2 (en) 56115, a novel human twik potassium channel and uses therefor
US20020177148A1 (en) FBH58295FL, a novel human amino acid transporter and uses thereof
US20030049727A1 (en) 25658, a novel human calcium channel subunit and uses thereof
WO2001081416A2 (en) Human ion channel and uses thereof

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20221108